Persistence and Evolution of SARS-CoV-2 in an Immunocompromised HostBina Choi, Jonathan Z. Li, Manish C. Choudhary et al.|New England Journal of Medicine|2020Cited by 1.4k
CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21Huabiao Chen, Mathias Lichterfeld|Journal of Clinical Investigation|2011Cited by 169
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus InfectionLine K. Vibholm, Ole S. Søgaard, Jørgen Agnholt et al.|Clinical Infectious Diseases|2017Cited by 146
Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case studyNathan W. Cummins, Andrew D. Badley, Stacey A. Rizza et al.|PLoS Medicine|2017Cited by 61